Friday 9 February 2018
Royal Society of Medicine
1 Wimpole Street
2 CPD Points
Dexmedetomidine has recently been adopted by the UK anaesthesia and intensive care communities following an extensive history of use in veterinary medicine. This evening meeting will provide a synopsis of its clinical utility and information regarding practical applications in different patient cohorts, in relation to both anaesthesia and critical care. An expert panel will discuss potential advantages and disadvantages and where pain fits in this continuum of use will be addressed. To contribute to this discussion book your place today.
A broad demographic of anaesthetists, intensive care clinicians, specialist veterinary surgeons and those with an interest in pain medicine.
The programme and speaker line up will be updated regularly.
Registration, tea and coffee
Welcome and introduction
Ms Louise Clark, President Elect, Pain Medicine Section, Royal Society of Medicine
Dexmedetomidine – what it is and what it does: Mechanisms and clinical pharmacology
Dr Joanna Murrell, Reader in Veterinary Anaesthesia, University of Bristol
Dexmedetomidine: What can it offer the anaesthetist?
Dr Joe Sebastian, Consultant Neuroanaesthetist, Salford Royal Hospital NHS Foundation Trust
Dexmedetomidine in cardiac anaesthesia and critical care
Dr Daniel Aston, Anaesthetist, Imperial College London
Panel discussion: Where does pain fit in all this?
Speaker panel and colleagues from the floor. Please bring your clinical questions, quandaries and conundrums for discussion.
Presentation: The Andrew Lawson prize
Dr Juliet Cohen
Closing remarks and Close of meeting
View rates for all membership types:View rates
For information on this event, contact Daisy GeorgeTel: 02072902982 Email: email@example.com